• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Response to: Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination".

作者信息

Albertson Timothy E, Hansen Caitlin, Gayed Juleen, Xu Xia, Feng Ye, Ma Hua

机构信息

UC Davis Medical Center, Sacramento, CA, USA.

Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.

出版信息

Infect Dis Ther. 2025 May;14(5):1137-1141. doi: 10.1007/s40121-025-01138-x. Epub 2025 Apr 7.

DOI:10.1007/s40121-025-01138-x
PMID:40193007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12084184/
Abstract
摘要

相似文献

1
A Response to: Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination".对《致编辑的信：关于BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估》的回复
Infect Dis Ther. 2025 May;14(5):1137-1141. doi: 10.1007/s40121-025-01138-x. Epub 2025 Apr 7.
2
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估
Infect Dis Ther. 2024 Apr;13(4):699-714. doi: 10.1007/s40121-024-00927-0. Epub 2024 Mar 15.
3
Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024.致编辑的信：关于阿尔伯森等人于2024年发表的《BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估》
Infect Dis Ther. 2025 May;14(5):1133-1136. doi: 10.1007/s40121-025-01136-z. Epub 2025 Apr 7.
4
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.BNT162b2 和 mRNA-1273 新冠疫苗接种后的心肌炎和心包炎风险。
Vaccine. 2022 Aug 19;40(35):5153-5159. doi: 10.1016/j.vaccine.2022.07.007. Epub 2022 Jul 12.
5
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.mRNA COVID-19 疫苗接种后的心肌炎和/或心包炎风险：BNT162b2 和 mRNA-1273 疫苗的加拿大头对头比较。
Vaccine. 2022 Jul 30;40(32):4663-4671. doi: 10.1016/j.vaccine.2022.05.048. Epub 2022 May 25.
6
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.泰国新冠疫苗接种后的心肌炎和心包炎
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.
7
Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines.接种Ad26.COV2.S、BNT162b2 mRNA或mRNA-1273新冠病毒疫苗个体的心肌炎和心包炎
Front Cardiovasc Med. 2023 Nov 24;10:1210007. doi: 10.3389/fcvm.2023.1210007. eCollection 2023.
8
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测：多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
9
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎（COVID-19）疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制：基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
10
Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.加拿大安大略省 12 至 17 岁人群接种 BNT162b2 疫苗后的心肌炎或心包炎事件。
JAMA Pediatr. 2023 Apr 1;177(4):410-418. doi: 10.1001/jamapediatrics.2022.6166.

本文引用的文献

1
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.BNT162b2疫苗接种后5至30岁人群的血清肌钙蛋白I评估
Infect Dis Ther. 2024 Apr;13(4):699-714. doi: 10.1007/s40121-024-00927-0. Epub 2024 Mar 15.
2
Simple improved confidence intervals for comparing matched proportions.用于比较匹配比例的简单改进置信区间。
Stat Med. 2005 Mar 15;24(5):729-40. doi: 10.1002/sim.1781.